Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$105.28 - $135.9 $200,032 - $258,210
1,900 New
1,900 $248,000
Q4 2022

Feb 13, 2023

BUY
$187.24 - $242.74 $1.5 Million - $1.94 Million
8,000 New
8,000 $1.62 Million
Q1 2021

May 13, 2021

SELL
$361.28 - $504.76 $1.55 Million - $2.17 Million
-4,300 Reduced 49.43%
4,400 $1.69 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $1.18 Million - $1.76 Million
4,400 Added 102.33%
8,700 $2.69 Million
Q2 2020

Aug 12, 2020

SELL
$256.46 - $373.01 $7.54 Million - $11 Million
-29,400 Reduced 87.24%
4,300 $1.59 Million
Q1 2020

May 13, 2020

SELL
$209.2 - $335.53 $11.9 Million - $19.1 Million
-56,900 Reduced 62.8%
33,700 $9.2 Million
Q4 2019

Feb 10, 2020

BUY
$288.29 - $335.49 $16.9 Million - $19.7 Million
58,700 Added 184.01%
90,600 $30.1 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $587,048 - $832,106
2,200 Added 7.41%
31,900 $9.71 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $4.36 Million - $5.34 Million
14,500 Added 95.39%
29,700 $10.9 Million
Q1 2019

May 15, 2019

SELL
$272.57 - $321.18 $4.14 Million - $4.88 Million
-15,200 Reduced 50.0%
15,200 $4.72 Million
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $1.04 Million - $1.39 Million
3,800 Added 14.29%
30,400 $9.12 Million
Q3 2018

Nov 14, 2018

SELL
$279.04 - $367.06 $725,504 - $954,356
-2,600 Reduced 8.9%
26,600 $9.76 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $4.08 Million - $5.23 Million
17,900 Added 158.41%
29,200 $8.16 Million
Q1 2018

May 15, 2018

SELL
$209.54 - $253.91 $7.88 Million - $9.55 Million
-37,600 Reduced 76.89%
11,300 $2.67 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $7.2 Million - $8.19 Million
35,600 Added 267.67%
48,900 $10.7 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $2.29 Million - $2.85 Million
13,300
13,300 $2.65 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.